Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
Chronic pain affects almost 10 million people in the UK but despite this, few effective treatments exist. Research has shown that targeting the Nav1.7 ion channel provides a novel approach to treatment. ProTx-II, a 30 amino acid peptide isolated from Tarantula venom, is highly selective for the chan...
Main Author: | Wright, Z. V. F. |
---|---|
Published: |
University College London (University of London)
2015
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654707 |
Similar Items
-
A Chemical Biology Approach to Probing the Folding Pathways of the Inhibitory Cystine Knot (ICK) Peptide ProTx-II
by: Stephen McCarthy, et al.
Published: (2020-04-01) -
Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice
by: Tanaka KI, et al.
Published: (2015-06-01) -
Tarantula Toxin ProTx-I Differentiates Between Human T-type Voltage-Gated Ca2+ Channels Cav3.1 and Cav3.2
by: Tsuyako Ohkubo, et al.
Published: (2010-01-01) -
Novel approaches to the synthesis of Wieland-Miescher ketone analogues
by: Turner, R. L.
Published: (2014) -
Synthesis of daunorubicin analogues
by: Page, P. C.
Published: (1981)